John Ojeifo

792 total citations
19 papers, 621 citations indexed

About

John Ojeifo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, John Ojeifo has authored 19 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in John Ojeifo's work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Virus-based gene therapy research (2 papers). John Ojeifo is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Virus-based gene therapy research (2 papers). John Ojeifo collaborates with scholars based in United States, Australia and Nigeria. John Ojeifo's co-authors include Richard G. Pestell, Xiaoming Ju, Sanjay Katiyar, Manran Liu, Xuanmao Jiao, Michael P. Lisanti, Mathew C. Casimiro, Chenguang Wang, David A. Joyce and Toshiyuki Sakamaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and American Journal Of Pathology.

In The Last Decade

John Ojeifo

19 papers receiving 613 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Ojeifo United States 10 416 250 211 60 58 19 621
Elsie White United States 7 443 1.1× 187 0.7× 153 0.7× 83 1.4× 28 0.5× 7 613
Christine Wittig Germany 7 396 1.0× 164 0.7× 163 0.8× 36 0.6× 28 0.5× 8 584
Ruo-Pan Huang United States 7 341 0.8× 121 0.5× 115 0.5× 89 1.5× 39 0.7× 9 573
LS Steelman United States 12 370 0.9× 200 0.8× 78 0.4× 77 1.3× 46 0.8× 20 508
Carla L. Van Den Berg United States 15 586 1.4× 284 1.1× 152 0.7× 65 1.1× 51 0.9× 18 768
Chungyoul Choe United States 13 505 1.2× 214 0.9× 162 0.8× 45 0.8× 31 0.5× 20 690
Nicolás Herranz Spain 7 614 1.5× 251 1.0× 158 0.7× 72 1.2× 48 0.8× 10 790
Stephanie Cabarcas‐Petroski United States 13 616 1.5× 311 1.2× 278 1.3× 56 0.9× 35 0.6× 23 840
KangAe Lee United States 6 444 1.1× 175 0.7× 391 1.9× 51 0.8× 80 1.4× 6 832
K Sudo Japan 10 405 1.0× 227 0.9× 192 0.9× 33 0.6× 32 0.6× 19 574

Countries citing papers authored by John Ojeifo

Since Specialization
Citations

This map shows the geographic impact of John Ojeifo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Ojeifo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Ojeifo more than expected).

Fields of papers citing papers by John Ojeifo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Ojeifo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Ojeifo. The network helps show where John Ojeifo may publish in the future.

Co-authorship network of co-authors of John Ojeifo

This figure shows the co-authorship network connecting the top 25 collaborators of John Ojeifo. A scholar is included among the top collaborators of John Ojeifo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Ojeifo. John Ojeifo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ochs‐Balcom, Heather M., Lynette Phillips, Hazel B. Nichols, et al.. (2015). Building a Funded Research Program in Cancer Health Disparities: Considerations for Young Investigators. Cancer Epidemiology Biomarkers & Prevention. 24(5). 882–885. 1 indexed citations
2.
Liu, Manran, Toshiyuki Sakamaki, Mathew C. Casimiro, et al.. (2010). The Canonical NF-κB Pathway Governs Mammary Tumorigenesis in Transgenic Mice and Tumor Stem Cell Expansion. Cancer Research. 70(24). 10464–10473. 177 indexed citations
3.
Tian, Lifeng, Jie Zhou, Mathew C. Casimiro, et al.. (2009). Activating Peroxisome Proliferator-Activated Receptor γ Mutant Promotes Tumor Growth In vivo by Enhancing Angiogenesis. Cancer Research. 69(24). 9236–9244. 42 indexed citations
4.
Liu, Manran, Xiaoming Ju, Nicole E. Willmarth, et al.. (2009). Nuclear Factor-κB Enhances ErbB2-Induced Mammary Tumorigenesis and Neoangiogenesis in Vivo. American Journal Of Pathology. 174(5). 1910–1920. 38 indexed citations
5.
Dailey, Vernon, et al.. (2008). Endothelial Progenitor Cells Significantly Contribute to Vasculatures in Human and Mouse Breast Tumors. 2(1). 30–61. 7 indexed citations
6.
Ju, Xiaoming, Sanjay Katiyar, Chenguang Wang, et al.. (2007). Akt1 governs breast cancer progression in vivo. Proceedings of the National Academy of Sciences. 104(18). 7438–7443. 162 indexed citations
7.
Fricke, Stanley T., Olga Rodriguez, John W. VanMeter, et al.. (2006). In vivo magnetic resonance volumetric and spectroscopic analysis of mouse prostate Cancer Models. The Prostate. 66(7). 708–717. 38 indexed citations
8.
Ojeifo, John, Aiguo Wu, Herbert B. Herscowitz, & Kenneth R. Meehan. (2003). Phenotypic and Immunologic Characteristics of Docetaxel-Mobilized Peripheral Blood Stem Cells in Mice. Journal of Hematotherapy & Stem Cell Research. 12(2). 189–197. 1 indexed citations
9.
Ojeifo, John, et al.. (2001). Endothelial cell–based systemic gene therapy of metastatic melanoma. Cancer Gene Therapy. 8(9). 636–648. 19 indexed citations
10.
Ojeifo, John, et al.. (2001). Isolation of Tumor-Derived Endothelial Cells. Microvascular Research. 61(3). 287–290. 5 indexed citations
11.
Zwiebel, James A., Ning Su, Scott Freeman, & John Ojeifo. (1997). Angiogenesis-directed incorporation of genetically-modified endothelial cells as systemic anti-tumor therapy. European Journal of Cancer. 33. S54–S54. 1 indexed citations
12.
Ojeifo, John, Ning Su, Una Ryan, et al.. (1996). Towards endothelial-cell-directed cancer immunotherapy: in vitro expression of human recombinant cytokine genes by human and mouse primary endothelial cells.. PubMed. 2(2). 89–101. 9 indexed citations
13.
Ojeifo, John, Reza Forough, Seung Woon Paik, T Maciag, & James A. Zwiebel. (1995). Angiogenesis-directed implantation of genetically modified endothelial cells in mice.. PubMed. 55(11). 2240–4. 27 indexed citations
14.
Su, Ning, et al.. (1994). Breast cancer gene therapy: transgenic immunotherapy. Breast Cancer Research and Treatment. 31(2-3). 349–356. 12 indexed citations
15.
Takamiya, Yoshiaki, Harold Brem, John Ojeifo, Toshihiro Mineta, & Robert L. Martuza. (1994). AGM-1470 Inhibits the Growth of Human Glioblastoma Cells in Vitro and in Vivo. Neurosurgery. 34(5). 869–875. 46 indexed citations
16.
Takamiya, Yoshiaki, Harold Brem, John Ojeifo, Toshihiro Mineta, & Robert L. Martuza. (1994). AGM-1470 Inhibits the Growth of Human Glioblastoma Cells in Vitro and in Vivo. Neurosurgery. 34(5). 869–875. 8 indexed citations
17.
Ojeifo, John, Stephen W. Byers, Vassilios Papadopoulos, & Martin Dym. (1990). Sertoli cell-secreted protein(s) stimulates DNA synthesis in purified rat Leydig cells in vitro. Reproduction. 90(1). 93–108. 19 indexed citations
18.
Ojeifo, John, et al.. (1988). What anatomy shall we teach medical and dental students in a primary health care curriculum?. Medical Education. 22(5). 407–411. 1 indexed citations
19.
Ojeifo, John, Stephen J. Winters, & Philip Troen. (1984). Basal and adrenocorticotropic hormone-stimulated serum 17α-hydroxyprogesterone in men with idiopathic infertility. Fertility and Sterility. 42(1). 97–101. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elsie White Breakdown of academic impact, for papers by Christine Wittig Breakdown of academic impact, for papers by Ruo-Pan Huang Breakdown of academic impact, for papers by LS Steelman Breakdown of academic impact, for papers by Carla L. Van Den Berg Breakdown of academic impact, for papers by Chungyoul Choe Breakdown of academic impact, for papers by Nicolás Herranz Breakdown of academic impact, for papers by Stephanie Cabarcas‐Petroski Breakdown of academic impact, for papers by KangAe Lee Breakdown of academic impact, for papers by K Sudo
Rankless by CCL
2026